Drug Shortage Report for VENLAFAXINE XR

Last updated on 2025-01-14 History
Report ID 244301
Drug Identification Number 02354748
Brand name VENLAFAXINE XR
Common or Proper name VENLAFAXINE XR
Company Name SANIS HEALTH INC
Market Status MARKETED
Active Ingredient(s) VENLAFAXINE
Strength(s) 150MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 500
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-12-02
Estimated end date 2025-01-17
Actual end date 2025-01-13
Shortage status Resolved
Updated date 2025-01-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1 PRESIDENTS CHOICE CIRCLE
BRAMPTON, ONTARIO
CANADA L6Y 5S5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2025-01-14 English Compare
v7 2025-01-13 French Compare
v6 2025-01-13 English Compare
v5 2025-01-08 French Compare
v4 2025-01-08 English Compare
v3 2024-12-03 English Compare
v2 2024-12-02 French Compare
v1 2024-12-02 English Compare

Showing 1 to 8 of 8